Photo credit: BioNTech

UBC-grown biotech companies lead global pandemic efforts

Posted on

Millions of Canadians have received the Pfizer-BioNTech COVID-19 vaccine, but what many may not realize is that a key component of the injection was developed right here at UBC.

Acuitas Therapeutics, a UBC spin-off company co-founded by Dr. Pieter Cullis, developed the lipid nanoparticle technology that allows the Pfizer-BioNTech mRNA vaccine to enter human cells….

https://news.ubc.ca/2021/04/26/ubc-grown-biotech-companies-lead-global-pandemic-efforts

 

Read More Impact Stories

Posted on

A first look inside Li-ion batteries

What if you could charge your electric vehicle in the same amount of time it takes to fill a tank [...]
Read more
Posted on

Harnessing AI to help pinpoint cancerous tumours

University of Waterloo engineers use AI to advance cancer treatment monitoring Engineers from the University of Waterloo are harnessing artificial [...]
Read more
Posted on

Researchers use powerful AI tool to gain new insights into protein structures

The findings could lead to a better understanding of the role played by proteins in disease and the development of [...]
Read more
View All Impact Stories